MarketCap
Facebook
X
TelegramQuarterly report 2024-Q2
added 08-12-2024
Agile Therapeutics Cash Conversion Cycle 2011-2026 | AGRX
Annual Cash Conversion Cycle Agile Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -206 | -295 | -90.9 | -4.58 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -90.9 | -4.58 K | -1.29 K |
Quarterly Cash Conversion Cycle Agile Therapeutics
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -522 | -361 | - | -94.3 | -170 | -254 | - | -322 | -258 | -353 | - | 1.61 | -234 | 148 | 105 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 148 | -522 | -193 |
Cash Conversion Cycle of other stocks in the Drug manufacturers industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
-38 | - | 7.5 % | $ 6.35 M |  USA |
 |
Alimera Sciences
ALIM
|
-128 | - | - | $ 142 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
460 | - | - | $ 754 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-224 | - | 0.86 % | $ 117 M | USA |
 |
Aurora Cannabis
ACB
|
1.45 K | $ 3.32 | 0.3 % | $ 86.3 M |  Canada |
 |
China Pharma Holdings
CPHI
|
164 | $ 0.57 | -9.62 % | $ 9.95 M |  China |
 |
Catalent
CTLT
|
110 | - | - | $ 11.5 B | USA |
 |
Athenex
ATNX
|
137 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
192 | - | - | $ 2.06 B |  France |
 |
Cronos Group
CRON
|
213 | $ 2.58 | 2.38 % | $ 1.34 B | Canada |
 |
DURECT Corporation
DRRX
|
41.4 | - | - | $ 50.1 M | USA |
 |
Emergent BioSolutions
EBS
|
181 | $ 8.01 | -0.5 % | $ 410 M | USA |
 |
Endo International plc
ENDP
|
141 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
45.7 | - | - | $ 36.6 M | USA |
 |
Pacira BioSciences
PCRX
|
209 | $ 23.2 | 2.43 % | $ 1.07 B | USA |
 |
HEXO Corp.
HEXO
|
775 | - | 2.45 % | $ 38.1 M | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
-161 | $ 3.13 | 2.62 % | $ 44 M | USA |
 |
Bausch Health Companies
BHC
|
78.9 | $ 4.99 | -2.25 % | $ 1.82 B | Canada |
 |
Perrigo Company plc
PRGO
|
137 | $ 9.64 | 0.73 % | $ 1.34 B | USA |
 |
Harrow Health
HROW
|
18.3 | $ 35.2 | 3.53 % | $ 1.29 B | USA |
 |
OptiNose
OPTN
|
314 | - | - | $ 1.08 B | USA |
 |
Evolus
EOLS
|
74.8 | $ 4.43 | -5.34 % | $ 286 M | USA |
 |
Rockwell Medical
RMTI
|
45 | $ 1.03 | 0.98 % | $ 24 M | USA |
 |
SCYNEXIS
SCYX
|
106 | $ 0.9 | 2.8 % | $ 44.9 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
150 | $ 2.34 | -8.24 % | $ 2.9 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
139 | - | -39.89 % | $ 27.7 M | USA |
 |
Tilray
TLRY
|
169 | $ 6.66 | 3.26 % | $ 4.12 B | Canada |
 |
OrganiGram Holdings
OGI
|
2.92 K | $ 1.34 | -1.47 % | $ 402 M | Canada |
 |
PetIQ
PETQ
|
53.8 | - | 1.64 % | $ 400 M | USA |
 |
PLx Pharma
PLXP
|
111 | - | -27.8 % | $ 2.56 M | USA |
 |
ProPhase Labs
PRPH
|
96 | - | - | $ 5.07 M | USA |
 |
Veru
VERU
|
6.7 | $ 2.29 | -0.43 % | $ 309 M | USA |
 |
Jupiter Wellness
JUPW
|
-21.1 | - | - | $ 33.6 M | USA |
 |
TherapeuticsMD
TXMD
|
-723 | $ 2.29 | -0.87 % | $ 23.9 M | USA |
 |
Viatris
VTRS
|
155 | $ 13.36 | 0.53 % | $ 16 B | USA |
 |
Radius Health
RDUS
|
-53.5 | - | - | $ 1.42 B | USA |
 |
Lannett Company
LCI
|
173 | - | 1.15 % | $ 7.11 M | USA |
 |
cbdMD
YCBD
|
92 | $ 0.77 | 1.06 % | $ 3.32 M | USA |
 |
Organogenesis Holdings
ORGO
|
64.5 | $ 2.41 | -2.43 % | $ 317 M | USA |
 |
Canopy Growth Corporation
CGC
|
177 | $ 0.96 | -0.87 % | $ 103 M | Canada |
 |
Assertio Holdings
ASRT
|
467 | $ 16.51 | 17.93 % | $ 106 M | USA |
 |
Recro Pharma
REPH
|
105 | - | -4.76 % | $ 65.3 M | USA |